Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 24 studies | 40% ± 16% | |
| endothelial cell | 22 studies | 30% ± 12% | |
| astrocyte | 15 studies | 36% ± 16% | |
| fibroblast | 12 studies | 27% ± 10% | |
| pericyte | 12 studies | 27% ± 8% | |
| macrophage | 11 studies | 28% ± 11% | |
| microglial cell | 11 studies | 25% ± 8% | |
| oligodendrocyte precursor cell | 11 studies | 31% ± 12% | |
| oligodendrocyte | 11 studies | 29% ± 10% | |
| glutamatergic neuron | 10 studies | 45% ± 27% | |
| GABAergic neuron | 9 studies | 45% ± 25% | |
| basal cell | 9 studies | 32% ± 20% | |
| ciliated cell | 9 studies | 27% ± 11% | |
| adipocyte | 9 studies | 29% ± 7% | |
| epithelial cell | 8 studies | 40% ± 21% | |
| myofibroblast cell | 7 studies | 37% ± 12% | |
| neuron | 6 studies | 38% ± 17% | |
| interneuron | 6 studies | 46% ± 22% | |
| myeloid cell | 6 studies | 25% ± 6% | |
| cardiac muscle cell | 6 studies | 62% ± 20% | |
| dendritic cell | 6 studies | 21% ± 3% | |
| Mueller cell | 6 studies | 33% ± 9% | |
| endothelial cell of lymphatic vessel | 6 studies | 26% ± 6% | |
| type I pneumocyte | 6 studies | 34% ± 10% | |
| type II pneumocyte | 6 studies | 30% ± 10% | |
| secretory cell | 5 studies | 19% ± 4% | |
| club cell | 5 studies | 30% ± 9% | |
| retinal cone cell | 5 studies | 19% ± 4% | |
| mesothelial cell | 5 studies | 34% ± 15% | |
| respiratory goblet cell | 5 studies | 33% ± 12% | |
| T cell | 5 studies | 23% ± 5% | |
| monocyte | 5 studies | 29% ± 5% | |
| squamous epithelial cell | 4 studies | 38% ± 20% | |
| granule cell | 4 studies | 29% ± 6% | |
| lymphocyte | 4 studies | 28% ± 7% | |
| amacrine cell | 4 studies | 21% ± 4% | |
| retina horizontal cell | 4 studies | 21% ± 5% | |
| retinal rod cell | 4 studies | 19% ± 3% | |
| endothelial cell of vascular tree | 4 studies | 24% ± 9% | |
| muscle cell | 4 studies | 48% ± 26% | |
| myoepithelial cell | 4 studies | 35% ± 20% | |
| classical monocyte | 3 studies | 23% ± 4% | |
| GABAergic interneuron | 3 studies | 32% ± 2% | |
| retinal ganglion cell | 3 studies | 25% ± 7% | |
| B cell | 3 studies | 25% ± 6% | |
| plasma cell | 3 studies | 31% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 5% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| GABAergic amacrine cell | 3 studies | 20% ± 4% | |
| glycinergic amacrine cell | 3 studies | 20% ± 1% | |
| hepatocyte | 3 studies | 52% ± 20% | |
| retinal pigment epithelial cell | 3 studies | 40% ± 20% | |
| neural progenitor cell | 3 studies | 26% ± 5% | |
| ependymal cell | 3 studies | 44% ± 18% | |
| alveolar macrophage | 3 studies | 35% ± 8% | |
| natural killer cell | 3 studies | 24% ± 4% | |
| goblet cell | 3 studies | 38% ± 27% | |
| transit amplifying cell | 3 studies | 41% ± 36% | |
| mast cell | 3 studies | 26% ± 9% | |
| mucus secreting cell | 3 studies | 36% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 12498.27 | 1444 / 1445 | 100% | 20.71 | 183 / 183 |
| prostate | 100% | 7139.84 | 244 / 245 | 100% | 20.46 | 500 / 502 |
| intestine | 100% | 14143.83 | 962 / 966 | 99% | 14.64 | 521 / 527 |
| bladder | 100% | 14775.14 | 21 / 21 | 98% | 13.48 | 494 / 504 |
| breast | 99% | 4051.17 | 453 / 459 | 99% | 17.74 | 1108 / 1118 |
| uterus | 100% | 11474.05 | 170 / 170 | 97% | 15.82 | 447 / 459 |
| ovary | 99% | 4137.16 | 179 / 180 | 98% | 8.40 | 420 / 430 |
| thymus | 99% | 3764.56 | 647 / 653 | 98% | 10.82 | 591 / 605 |
| lung | 96% | 2941.51 | 557 / 578 | 100% | 13.80 | 1153 / 1155 |
| stomach | 91% | 7755.93 | 327 / 359 | 98% | 19.73 | 281 / 286 |
| adrenal gland | 99% | 4135.45 | 256 / 258 | 90% | 7.92 | 207 / 230 |
| skin | 99% | 3663.71 | 1790 / 1809 | 89% | 9.12 | 420 / 472 |
| kidney | 82% | 2040.06 | 73 / 89 | 95% | 9.85 | 853 / 901 |
| brain | 66% | 1782.74 | 1738 / 2642 | 99% | 8.76 | 699 / 705 |
| pancreas | 31% | 584.31 | 101 / 328 | 98% | 15.79 | 175 / 178 |
| blood vessel | 100% | 15003.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.03 | 1 / 1 |
| muscle | 99% | 5217.80 | 797 / 803 | 0% | 0 | 0 / 0 |
| adipose | 98% | 3783.73 | 1175 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 13.54 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 7.57 | 27 / 29 |
| heart | 92% | 8610.04 | 790 / 861 | 0% | 0 | 0 / 0 |
| liver | 15% | 273.75 | 33 / 226 | 77% | 4.83 | 313 / 406 |
| spleen | 64% | 1374.32 | 154 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 50% | 2.79 | 40 / 80 |
| peripheral blood | 40% | 1203.98 | 375 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072659 | Biological process | protein localization to plasma membrane |
| GO_1905150 | Biological process | regulation of voltage-gated sodium channel activity |
| GO_0006936 | Biological process | muscle contraction |
| GO_1900825 | Biological process | regulation of membrane depolarization during cardiac muscle cell action potential |
| GO_1902305 | Biological process | regulation of sodium ion transmembrane transport |
| GO_0035331 | Biological process | negative regulation of hippo signaling |
| GO_0005790 | Cellular component | smooth endoplasmic reticulum |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0005813 | Cellular component | centrosome |
| GO_0031430 | Cellular component | M band |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0042383 | Cellular component | sarcolemma |
| GO_0030018 | Cellular component | Z disc |
| GO_0090443 | Cellular component | FAR/SIN/STRIPAK complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLMAP |
| Protein name | Sarcolemma associated protein Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein) |
| Synonyms | UNQ1847/PRO3577 KIAA1601 SLAP |
| Description | FUNCTION: May play a role during myoblast fusion. . |
| Accessions | H7BZW9 A0A590UJU9 ENST00000657480.1 ENST00000460223.1 ENST00000705630.1 ENST00000417128.7 A0A994J4X6 H7C5S2 A0A994J5K5 ENST00000655012.1 ENST00000705650.1 ENST00000671191.1 A0A590UJK3 ENST00000705649.1 ENST00000295951.7 [Q14BN4-3] ENST00000705651.1 H7C3M8 A0A590UK66 ENST00000658689.1 A0A994J7U9 ENST00000705648.1 ENST00000705653.1 A0A994J558 A0A994J5K8 ENST00000475055.2 ENST00000295952.7 [Q14BN4-3] A0A590UJS6 H7C5G9 A0A590UJG7 ENST00000664084.1 A0A5F9VB99 A0A994J562 ENST00000416658.5 ENST00000465203.6 A0A590UJH8 A0A590UJ91 ENST00000449503.6 [Q14BN4-2] A0A590UJ16 A0A994J4X9 ENST00000705629.1 ENST00000438794.6 ENST00000659926.1 ENST00000667800.1 Q14BN4 A0A994J7G6 A0A994J7V1 ENST00000383718.7 [Q14BN4-6] ENST00000705628.1 ENST00000670768.2 ENST00000428312.6 A0A590UJP6 ENST00000494088.6 [Q14BN4-5] ENST00000662629.1 H7BZK0 ENST00000705652.1 ENST00000659705.1 [Q14BN4-1] A0A590UJT5 |